PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PTCT 12.23.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2025-01-13
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
Full Press ReleaseSEC FilingsOur PTCT Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 01.13.2025 - 2025 J.P. Morgan Healthcare Conference
  • 01.13.2025 - PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.10.2025 - 144 Report of proposed sale of securities

WARREN, N.J.,Dec. 23, 2024/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEOMatthew B. Klein, M.D., will present at the 43rdAnnualJ.P. Morgan Healthcare ConferenceonMonday, January 13, 2025, at11:15 a.m. PST/2:15 p.m. EST.

The presentation will be webcast live on the Events and Presentations page under the Investors section ofPTC Therapeutics'website athttps://ir.ptcbio.com/events-presentationsand will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us atwww.ptcbio.comand follow us on Facebook, Instagram, LinkedIn and X.

For More Information:

Investors:Ellen Cavaleri+1 (615) 618-6228ecavaleri@ptcbio.com

Media:Jeanine Clemente+1 (908) 912-9406jclemente@ptcbio.com

CisionView original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302338079.html

SOURCEPTC Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com